Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations as follows: Guggenheim Healthcare Talks Idea Forum, Neuro/Immunology Day, at 11:15 a.m. EST on Monday, November...

Eli Lilly and Company (NYSE: LLY) announced today the 52-week results from the Phase 3b/4 SPIRIT-Head-to-Head (H2H) study of Taltz® (ixekizumab) versus Humira® (adalimumab) in biologic-naïve...

Hyster-Yale Materials Handling, Inc. (NYSE:HY) announced today that its management will participate in the 2019 Southwest Ideas Investor Conference taking place at the Westin Dallas Downtown in...

Xilinx Developer Forum Europe 2019 -- Xilinx, Inc., (NASDAQ: XLNX), the leader in adaptive and intelligent computing, today announced the expansion of its automotive-qualified 16 nanometer (nm)...